We've helped many biopharmaceutical companies advance their innovations through preclinical efficacy phases.
Whether the objective be to bring a compound to outlicensing stages, expand the therapeutic potential of already approved therapies or progress a compound to clinical trial phases, MD Biosciences can help. We are more than just a CRO, we are a research partner that can help design the studies based on the goals at hand. We understand the time and budget contraints that every research group is working under, whether you are a large pharma company or a small start-up. All studies are designed to maximize the amount of data that can be obtained from a single animal or cell. Additionally, we understand the link that resides between pain & inflammation and the targets that fall within the gap.
What will we bring to your project?
Flexibility to accomodate last minute study changes
Open communication so you know the status during your study
Scientific contribution to the study design
Innovative approaches to tackling problems
Wide range of ex vivo analysis including multiplex, PCR, histology, IHC
Wide range of behavior, cognitive and motor function tests
Willingness to validate new methods
IACUC and AAALAC oversight
GLP-like processes to bring quality and consistency to methods
How can you be sure? We'd be happy to share experiences from our sponsors. Just ask.